- Correction
- Open access
- Published:
Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox
BMC Cancer volume 23, Article number: 582 (2023)
The Original Article was published on 22 July 2020
Correction: BMC Cancer 20, 681 (2020)
https://doi.org/10.1186/s12885-020-07167-8
Following publication of the original article [1], the authors have identified an error, specifically the overlapping of the two images in Fig. 2a (24 h, DFX 10 μm and DFX 100 μM), which was pointed out to us by the editorial team. The corrected Fig. 2 is given in this correction article.
Effect of DFX on migratory ability of pancreatic cancer cells. Pancreatic cancer cell lines (BxPC-3, Panc-1, HPAFII) were treated with DFX (0, 10, 50, 100 μM) and incubated for 24 h. a-c Migrated cells were visualized via phase-contrast microscopy. d-f % wound closure was measured and the ratio to wound width at the start of the incubation was used as an index of cell migration, compared to control group (n = 3 each). Data are presented as mean ± SD. *P < 0.01 vs control
Reference
Amano S, Kaino S, Shinoda S, et al. Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox. BMC Cancer. 2020;20:681. https://doi.org/10.1186/s12885-020-07167-8.
Author information
Authors and Affiliations
Corresponding author
Additional information
The article to which this update relates has been retracted. Please see the retraction notice for more detail: https://doi.org/10.1186/s12885-023-11677-6
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Amano, S., Kaino, S., Shinoda, S. et al. Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox. BMC Cancer 23, 582 (2023). https://doi.org/10.1186/s12885-023-11091-y
Published:
DOI: https://doi.org/10.1186/s12885-023-11091-y